Literature DB >> 16813569

Cell cycle-dependent expression of cIAP2 at G2/M phase contributes to survival during mitotic cell cycle arrest.

Hyung-Seung Jin1, Tae H Lee.   

Abstract

cIAP2 (cellular inhibitor of apoptosis protein 2) is induced by NF-kappaB (nuclear factor kappaB) when cells need to respond quickly to different apoptotic stimuli. A recent study using cDNA microarray technology has suggested that cIAP2 transcription is regulated in a cell cycle-dependent manner, although the mechanism for such regulation is unknown. In this study, we confirmed the cell cycle-dependent regulation of cIAP2 expression at both the mRNA and protein levels. Additionally, we found that a bipartite CDE (cell cycle-dependent element)/CHR (cell cycle gene homology region) element in the cIAP2 promoter mediates cIAP2 gene activation in G2/M phase. Cell cycle-dependent G2/M-phase-specific cIAP2 expression is enhanced by NF-kappaB activation, and selective down-regulation of cIAP2 causes cells blocked in mitosis with nocodazole to become susceptible to apoptosis, indicating that the G2/M-phase-specific expression of cIAP2 contributes to the survival of mitotically arrested cells. Our studies describing the NF-kappaB-independent G2/M-phase-specific expression of cIAP2 will help in further understanding the molecular basis of cIAP2 over-expression in a variety of human cancers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16813569      PMCID: PMC1609902          DOI: 10.1042/BJ20060612

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  CHF: a novel factor binding to cyclin A CHR corepressor element.

Authors:  A Philips; S Chambeyron; N Lamb; A Vié; J M Blanchard
Journal:  Oncogene       Date:  1999-11-04       Impact factor: 9.867

2.  Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G(2)/M arrest in human cells.

Authors:  C Badie; J E Itzhaki; M J Sullivan; A J Carpenter; A C Porter
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

Review 3.  IAPs, RINGs and ubiquitylation.

Authors:  David L Vaux; John Silke
Journal:  Nat Rev Mol Cell Biol       Date:  2005-04       Impact factor: 94.444

4.  A new model of cell cycle-regulated transcription: repression of the cyclin A promoter by CDF-1 and anti-repression by E2F.

Authors:  N Liu; F C Lucibello; K Engeland; R Müller
Journal:  Oncogene       Date:  1998-06-11       Impact factor: 9.867

5.  CDF-1, a novel E2F-unrelated factor, interacts with cell cycle-regulated repressor elements in multiple promoters.

Authors:  N Liu; F C Lucibello; K Körner; L A Wolfraim; J Zwicker; R Müller
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

6.  Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-gamma and Fas.

Authors:  L P Wen; K Madani; J A Fahrni; S R Duncan; G D Rosen
Journal:  Am J Physiol       Date:  1997-11

7.  Cell cycle-dependent regulation of TIAP/m-survivin expression.

Authors:  M Otaki; M Hatano; K Kobayashi; T Ogasawara; T Kuriyama; T Tokuhisa
Journal:  Biochim Biophys Acta       Date:  2000-09-07

8.  Cell cycle regulation of the human polo-like kinase (PLK) promoter.

Authors:  T Uchiumi; D L Longo; D K Ferris
Journal:  J Biol Chem       Date:  1997-04-04       Impact factor: 5.157

9.  Involvement of two NF-kappa B binding elements in tumor necrosis factor alpha -, CD40-, and epstein-barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene.

Authors:  S Y Hong; W H Yoon; J H Park; S G Kang; J H Ahn; T H Lee
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

10.  The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins.

Authors:  M Rothe; M G Pan; W J Henzel; T M Ayres; D V Goeddel
Journal:  Cell       Date:  1995-12-29       Impact factor: 41.582

View more
  7 in total

1.  Integrating ChIP-sequencing and digital gene expression profiling to identify BRD7 downstream genes and construct their regulating network.

Authors:  Ke Xu; Wei Xiong; Ming Zhou; Heran Wang; Jing Yang; Xiayu Li; Pan Chen; Qianjin Liao; Hao Deng; Xiaoling Li; Guiyuan Li; Zhaoyang Zeng
Journal:  Mol Cell Biochem       Date:  2015-09-25       Impact factor: 3.396

2.  Circadian rhythm disruption impairs tissue homeostasis and exacerbates chronic inflammation in the intestine.

Authors:  René Pagel; Florian Bär; Torsten Schröder; Annika Sünderhauf; Axel Künstner; Saleh M Ibrahim; Stella E Autenrieth; Kathrin Kalies; Peter König; Anthony H Tsang; Dominik Bettenworth; Senad Divanovic; Hendrik Lehnert; Klaus Fellermann; Henrik Oster; Stefanie Derer; Christian Sina
Journal:  FASEB J       Date:  2017-07-14       Impact factor: 5.191

3.  Garlic constituent diallyl trisulfide suppresses x-linked inhibitor of apoptosis protein in prostate cancer cells in culture and in vivo.

Authors:  Su-Hyeong Kim; Ajay Bommareddy; Shivendra V Singh
Journal:  Cancer Prev Res (Phila)       Date:  2011-03-16

4.  Mechanism-based mathematical modeling of combined gemcitabine and birinapant in pancreatic cancer cells.

Authors:  Xu Zhu; Robert M Straubinger; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-08-08       Impact factor: 2.745

5.  The molecular mechanism of the anticancer effect of Artonin E in MDA-MB 231 triple negative breast cancer cells.

Authors:  Imaobong Christopher Etti; Rasedee Abdullah; Arifah Kadir; Najihah Mohd Hashim; Swee Keong Yeap; Mustapha Umar Imam; Faiqah Ramli; Ibrahim Malami; Kian Lim Lam; Ubong Etti; Peter Waziri; Marsitoh Rahman
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

6.  Targeting inhibitors of apoptosis proteins suppresses medulloblastoma cell proliferation via G2/M phase arrest and attenuated neddylation of p21.

Authors:  Shu-Mei Chen; Tzu-Kang Lin; Yuan-Yun Tseng; Chiao-Hui Tu; Tai-Ngar Lui; Shiang-Fu Huang; Ling-Ling Hsieh; Ying-Ying Li
Journal:  Cancer Med       Date:  2018-07-09       Impact factor: 4.452

7.  Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial.

Authors:  Fatéméh Dubois; Maureen Keller; Julien Hoflack; Elodie Maille; Martine Antoine; Virginie Westeel; Emmanuel Bergot; Elisabeth Quoix; Armelle Lavolé; Laurence Bigay-Game; Jean-Louis Pujol; Alexandra Langlais; Franck Morin; Gérard Zalcman; Guénaëlle Levallet
Journal:  Cancers (Basel)       Date:  2019-11-21       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.